A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
Clinical trial NCT04470427 · COMPLETED
Trial details
- NCT number
- NCT04470427
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-12-29
- Enrollment
- 30415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.